Sentiment-Signal
15,8
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
14.9
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Stammdaten
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
Unternehmen & Branche
| Name | Savara Inc |
|---|---|
| Ticker | SVRA |
| CIK | 0001160308 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 805111101 |
|---|---|
| ISIN | US8051111016 |
| Typ | Common Stock |
| Marktkapitalisierung | 1,16 Mrd. USD |
| Beta | 0,31 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | -118,837,000 | -0.53 | 253,436,000 | 203,133,000 | |
| 2025-09-30 | 10-Q | -29,561,000 | -0.14 | 140,924,000 | 94,386,000 | |
| 2025-06-30 | 10-Q | -30,401,000 | -0.14 | 163,765,000 | 120,484,000 | |
| 2025-03-31 | 10-Q | -26,639,000 | -0.12 | 189,316,000 | 147,850,000 | |
| 2024-12-31 | 10-K | -95,881,000 | -0.48 | 212,879,000 | 171,449,000 | |
| 2024-09-30 | 10-Q | -24,248,000 | -0.11 | 238,817,000 | 199,349,000 | |
| 2024-06-30 | 10-Q | -22,243,000 | -0.12 | 139,670,000 | 101,731,000 | |
| 2024-03-31 | 10-Q | -20,346,000 | -0.11 | 158,295,000 | 121,861,000 | |
| 2023-12-31 | 10-K | -54,698,000 | -0.33 | 177,564,000 | 140,372,000 | |
| 2023-09-30 | 10-Q | -16,599,000 | -0.10 | 182,072,000 | 146,544,000 | |
| 2023-06-30 | 10-Q | -11,443,000 | -0.07 | 119,833,000 | 87,715,000 | |
| 2023-03-31 | 10-Q | -10,557,000 | -0.07 | 129,359,000 | 98,255,000 | |
| 2022-12-31 | 10-K | -38,150,000 | -0.25 | 139,777,000 | 107,778,000 | |
| 2022-09-30 | 10-Q | -10,386,000 | -0.07 | 147,758,000 | 116,514,000 | |
| 2022-06-30 | 10-Q | -9,164,000 | -0.06 | 156,777,000 | 127,042,000 | |
| 2022-03-31 | 10-Q | -8,300,000 | -0.05 | 166,209,000 | 136,475,000 | |
| 2021-12-31 | 10-K | -43,014,000 | -0.32 | 176,598,000 | 144,498,000 | |
| 2021-09-30 | 10-Q | 0 | -10,546,000 | -0.07 | 187,274,000 | 155,229,000 |
| 2021-06-30 | 10-Q | -10,941,000 | -0.07 | 196,433,000 | 165,382,000 | |
| 2021-03-31 | 10-Q | -10,217,000 | 207,630,000 | 175,121,000 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| VR Adviser, LLC | 13,740,375 | 0 | 13,740,375 | 82,854,461 | Neu | +100,0% | |
| BlackRock, Inc. | 11,097,289 | 0 | 11,097,289 | 66,916,652 | Neu | +100,0% | |
| VANGUARD GROUP INC | 10,041,647 | 0 | 10,041,647 | 60,551,132 | Neu | +100,0% | |
| Frazier Life Sciences Management, L.P. | 9,862,301 | 0 | 9,862,301 | 59,469,675 | Neu | +100,0% | |
| Nantahala Capital Management, LLC | 7,344,783 | 0 | 7,344,783 | 44,289,041 | Neu | +100,0% | |
| RTW INVESTMENTS, LP | 5,952,380 | 0 | 5,952,380 | 35,892,851 | Neu | +100,0% | |
| MARSHALL WACE, LLP | 4,559,921 | 0 | 4,559,921 | 27,496,325 | Neu | +100,0% | |
| STATE STREET CORP | 4,333,022 | 0 | 4,333,022 | 26,128,123 | Neu | +100,0% | |
| EMERALD ADVISERS, LLC | 3,495,496 | 0 | 3,495,496 | 21,077,841 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 3,417,769 | 0 | 3,417,769 | 20,613,145 | Neu | +100,0% | |
| Rosalind Advisors, Inc. | 3,403,721 | 0 | 3,403,721 | 20,524,438 | Neu | +100,0% | |
| WELLINGTON MANAGEMENT GROUP LLP | 2,674,931 | 0 | 2,674,931 | 16,129,834 | Neu | +100,0% | |
| PERCEPTIVE ADVISORS LLC | 2,400,000 | 0 | 2,400,000 | 14,472,000 | Neu | +100,0% | |
| MORGAN STANLEY | 2,337,896 | 0 | 2,337,896 | 14,097,514 | Neu | +100,0% | |
| D. E. Shaw & Co., Inc. | 1,669,370 | 0 | 1,669,370 | 10,066,301 | Neu | +100,0% | |
| Vestal Point Capital, LP | 1,606,000 | 0 | 1,606,000 | 9,684,180 | Neu | +100,0% | |
| ADAR1 Capital Management, LLC | 1,405,452 | 0 | 1,405,452 | 8,474,876 | Neu | +100,0% | |
| SPHERA FUNDS MANAGEMENT LTD. | 1,178,164 | 0 | 1,178,164 | 7,104,329 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,161,672 | 0 | 1,161,672 | 7,004,882 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 1,077,625 | 0 | 1,077,625 | 6,498,078 | Neu | +100,0% | |
| Siren, L.L.C. | 1,000,000 | 0 | 1,000,000 | 6,030,000 | Neu | +100,0% | |
| SUPERSTRING CAPITAL MANAGEMENT LP | 995,353 | 0 | 995,353 | 6,001,979 | Neu | +100,0% | |
| Swedbank AB | 850,000 | 0 | 850,000 | 5,125,500 | Neu | +100,0% | |
| DEUTSCHE BANK AG\ | 824,717 | 0 | 824,717 | 4,973,044 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 803,992 | 0 | 803,992 | 4,848,072 | Neu | +100,0% | |
| VOYA INVESTMENT MANAGEMENT LLC | 751,255 | 0 | 751,255 | 4,530,068 | Neu | +100,0% | |
| Invesco Ltd. | 688,595 | 0 | 688,595 | 4,152,228 | Neu | +100,0% | |
| F/m Investments LLC | 678,813 | 0 | 678,813 | 4,093,242 | Neu | +100,0% | |
| JANE STREET GROUP, LLC | 614,189 | 0 | 614,189 | 3,703,560 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 577,556 | 0 | 577,556 | 3,482,663 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 534,968 | 0 | 534,968 | 3,225,857 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 516,598 | 0 | 516,598 | 3,115,086 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 423,596 | 0 | 423,596 | 2,554,284 | Neu | +100,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 332,100 | 0 | 332,100 | 2,002,563 | Neu | +100,0% | |
| BARCLAYS PLC | 306,940 | 0 | 306,940 | 1,850,848 | Neu | +100,0% | |
| UBS Group AG | 202,883 | 0 | 202,883 | 1,223,385 | Neu | +100,0% | |
| Eversept Partners, LP | 170,195 | 0 | 170,195 | 1,026,276 | Neu | +100,0% | |
| DIMENSIONAL FUND ADVISORS LP | 170,129 | 0 | 170,129 | 1,025,878 | Neu | +100,0% | |
| WELLS FARGO & COMPANY/MN | 167,644 | 0 | 167,644 | 1,010,894 | Neu | +100,0% | |
| RHUMBLINE ADVISERS | 152,775 | 0 | 152,775 | 921,225 | Neu | +100,0% | |
| Walleye Capital LLC | 150,084 | 0 | 150,084 | 905,007 | Neu | +100,0% | |
| ALLIANCEBERNSTEIN L.P. | 127,040 | 0 | 127,040 | 766,051 | Neu | +100,0% | |
| GROUP ONE TRADING LLC | 99,900 | 0 | 99,900 | 602,397 | Neu | +100,0% | |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 90,000 | 0 | 90,000 | 549,900 | Neu | +100,0% | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 86,160 | 0 | 86,160 | 519,545 | Neu | +100,0% | |
| Aquatic Capital Management LLC | 83,089 | 0 | 83,089 | 501,027 | Neu | +100,0% | |
| MetLife Investment Management, LLC | 78,551 | 0 | 78,551 | 473,663 | Neu | +100,0% | |
| Connor, Clark & Lunn Investment Management Ltd. | 74,882 | 0 | 74,882 | 451,538 | Neu | +100,0% | |
| OXFORD ASSET MANAGEMENT LLP | 74,115 | 0 | 74,115 | 446,913 | Neu | +100,0% | |
| JPMORGAN CHASE & CO | 73,059 | 0 | 73,059 | 440,546 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2025-12-19 | RAMSAY DAVID A | Director | Open Market Sale | -20,000 | 6.06 | -121,220.00 | -151,1% | |
| 2025-06-20 | Hawkins Richard J | Director | Open Market Purchase | 48,225 | 2.04 | 98,571.90 | +122,9% | |
| 2025-05-29 | McCracken Joseph S | Director | Open Market Purchase | 10,000 | 2.08 | 20,825.00 | +26,0% |
Fail-to-Deliver (6 Monate)
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-03-31 | 113 | 5,05 | 571 |
| 2026-03-26 | 5.611 | 5,28 | 29.626 |
| 2026-03-25 | 6.237 | 5,04 | 31.434 |
| 2026-03-02 | 622 | 6,02 | 3.744 |
Top-Fondshalter
Stand: 31.03.2026
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| OPPENHEIMER & CO INC | 15,500 | 84,630 | 100.00 |